Literature DB >> 20645528

Harnessing the anti-inflammatory effects of topical dapsone for management of acne.

Leon H Kircik1.   

Abstract

Data continue to establish the role of inflammation, not only in the pathogenesis of acne but also in the development of its most devastating sequelum, scarring. Although topical therapy is preferred by most acne patients and the physicians who treat them, historically no topical intervention has provided primarily anti-inflammatory effects. Topical dapsone 5% gel offers documented efficacy for the reduction of both inflammatory and non-inflammatory acne lesions. It has been proven safe, presenting none of the hematologic risks associated with oral dapsone. Data suggest the vehicle formulation enhances healing and contributes to tolerability, making topical dapsone 5% gel a worthwhile anti-inflammatory treatment for many patients with mild-to-moderate acne vulgaris.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645528

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

1.  A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.

Authors:  Viswanath R Belum; Michael A Marchetti; Stephen W Dusza; Andrea Cercek; Nancy E Kemeny; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09       Impact factor: 11.527

Review 2.  The role of inflammation in the pathology of acne.

Authors:  Emil A Tanghetti
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

3.  The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: A randomized double-blind study.

Authors:  Gita Faghihi; Mehrdad Rakhshanpour; Bahareh Abtahi-Naeini; Mohammad Ali Nilforoushzadeh
Journal:  Adv Biomed Res       Date:  2014-08-22

4.  Eugenol significantly affects the flow of its nanodroplet gel.

Authors:  Kannissery Pramod; Salim Shanavas; Shahid H Ansari; Javed Ali
Journal:  Int J Pharm Investig       Date:  2015 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.